Ancillary Medical Approaches to the Treatment of Sinusitis

  • Christopher Chang
  • Stanley Naguwa


Acute bacterial sinusitis and chronic bacterial sinusitis are often difficult to treat, especially in the patient with associated allergic disease. In addition to the infective inflammation caused by the bacteria in the sinuses, the presence of allergic rhinitis produces further inflammation both in the sinus mucosa and in the nasal pharynx, which is further complicated by a deficiency in mucociliary clearance, increased nasal secretion, and decreased drainage. Thus, the treatment of sinusitis often requires additional measures other than antibiotics, measures that may also ameliorate the need for surgical intervention (1).


Respiratory Syncytial Virus Allergic Rhinitis Fluticasone Propionate Allergy Clin Immunol Nasal Polyp 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Dohlman AW, Hemstreet MPB, Odrezin GT, Bartolucci AA. Subacute sinusitis: are anti-microbials necessary? J Allergy Clin Immunol 1993;91:1015–1023.PubMedCrossRefGoogle Scholar
  2. 2.
    Kaliner MA. Human nasal host defense and sinusitis. J Allergy Clin Immunol 1992;90:424–430.PubMedCrossRefGoogle Scholar
  3. 3.
    Sykes DA, Chan KL, Wilson R, MacKay IS, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. Lancet 1986;2:359,360.PubMedCrossRefGoogle Scholar
  4. 4.
    Wald, ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991;87:120–133.Google Scholar
  5. 5.
    Gwaltney JM, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330: 25–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Peter G, Halsey NA, Marcuse EK, Pickering LK, eds. 1994 Red Book: Report of the Committee on Infectious Diseases, 23rd ed., Elk Grove Village, IL: American Academy of Pediatrics, 1994; pp. 396–398.Google Scholar
  7. 7.
    Cidex Activated Dialdehyde Solution package insert. Arlington, TX: Johnson and Johnson Medical Inc., 1994.Google Scholar
  8. 8.
    Lewis FA, Rae ML, Lehmann NI, et al. A syncytial virus associated with epidemic disease of the lower respiratory tract in infants and young children. Med J Aust 1961; 2:932,933.Google Scholar
  9. 9.
    Hall CB, Douglas RG. Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child 1976;130:615–620.PubMedGoogle Scholar
  10. 10.
    Glezen WP, Denny FW. Epidemiology of acute lower respiratory tract disease of children. N Engl J Med 1973;288:498–505.PubMedCrossRefGoogle Scholar
  11. 11.
    Peter G, Halsey NA, Marcuse EK, Pickering LK, eds. 1994 Red Book: Report of the Committee on Infectious Diseases, 23rd ed., Elk Grove Village, IL: American Academy of Pediatrics, 1994; pp. 275–283.Google Scholar
  12. 12.
    Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infections: a randomized double-blind study. N Engl J Med 1983;308:1443–1447.PubMedCrossRefGoogle Scholar
  13. 13.
    Rodriguez WJ, Kim HW, Brandt CD, et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J 1987;6:159–163.PubMedCrossRefGoogle Scholar
  14. 14.
    Pinnock CB, Graham NV, Mylvagnanam A, Douglas RM. Relationship between milk intake and mucus production in adult volunteers challenged with rhinovirus-2. Am Rev Resp Dis 1990;141:352–356.PubMedGoogle Scholar
  15. 15.
    Haas F, Bishop MC, Salazar-Schicchi J, Axen KV, et al. Effect of milk ingestion on pulmonary function in healthy and asthmatic subjects. J Asthma 1991;28:349–355.PubMedCrossRefGoogle Scholar
  16. 16.
    Lowff A. Death and transfiguration of a problem. Bacteriol Rev 1969;33:390–403.Google Scholar
  17. 17.
    Tyrrell D, Barrow I, Arthur J. Local hyperthermia benefits natural and experimental common cold. Br Med J 1989;298:1280–1283.CrossRefGoogle Scholar
  18. 18.
    Macknin MC, Mathew S, Medendorp SV. Effects of inhaling heated vapor on symptoms of the common cold. JAMA 1990;264:989–991.PubMedCrossRefGoogle Scholar
  19. 19.
    Forstall GJ, Macknin ML, Yen-Leiberman BR, Medendorp SV. Effects of inhaling heated vapor on symptoms of the common cold. JAMA 1994;271:1109–1111.PubMedCrossRefGoogle Scholar
  20. 20.
    Yerushalmi A, Karman S, Lwoff S. Treatment of perennial allergic rhinitis by local hyperthermia. Proc Natl Acad Sci 1981;79:4766–4769.CrossRefGoogle Scholar
  21. 21.
    Ophir D, Elad Y, Dolev Z, Geller-Bernstein C. Effects of inhaled humidified warm air on nasal patency and nasal symptoms in allergic rhinitis. Ann Allergy 1988;60:239.PubMedGoogle Scholar
  22. 22.
    Shim C, King M, Williams MH. Lack of effect of hydration on sputum production in chronic bronchitis. Chest 1987;92:679–682.PubMedCrossRefGoogle Scholar
  23. 23.
    Ophir D, Elad Y. Effects of steam inhalation on nasal patency and nasal symptoms in patients with the common cold. Am J Otolaryngol 1987;3:149–153.CrossRefGoogle Scholar
  24. 24.
    Yerushalmi A, Lwoff A. Traiteniente du coryza infectieux des rhinities persistantes allergiques par la thermotherapie. CR Acad Sci (D) Paris 1987;281:957–959.Google Scholar
  25. 25.
    Bang BC, Mukherjee AL, Bang FB. Human nasal mucous flow rates. Johns Hopkins Med J 1967;121:38–48.Google Scholar
  26. 26.
    Ingels KJAO, Kortman MJW, Nijziel MR, et al. Factorsinfluencing ciliary beat measurements. Rhinology 1991;29:17–26.PubMedGoogle Scholar
  27. 27.
    Sakethoo K, Januszkiewicz A, Sackner MA. Effects of drinking hot water, cold water and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 1978;74:408–410.CrossRefGoogle Scholar
  28. 28.
    Spector SL. The role of allergy in sinusitis in adults. J Allergy Clin Immunol. 1992;90:518–520.PubMedCrossRefGoogle Scholar
  29. 29.
    Slavin RG. Nasal polyps and sinusitis. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, et al., eds., Allergy: Principles and Practice. St. Louis: Mosby-Yearbook, 1993; pp. 1455–1470.Google Scholar
  30. 30.
    Kreaemer MJ, Richardson MA, Weiss NS, et al. Risk factors for persistent middle-ear effusions. JAMA 1983; 249:1022–1025.CrossRefGoogle Scholar
  31. 31.
    Said G, Zalokar J, Lellouch J, Patois E. Parental smoking related to adenoidectomy and tonsillectomy in children. J Epidemiol Community Health 1978;32:97–101.PubMedCrossRefGoogle Scholar
  32. 32.
    Iversen M, Birch L, Lundqvist GR, Elbrond O. Middle ear effusions in children and the indoor environment: an epidemiological study. Arch Environ Health 1985;40: 74–79.PubMedCrossRefGoogle Scholar
  33. 33.
    Forastiere F, Corbo GM, Michelozzi P, Pistell R, et al. Effects of environment and passive smoking on the respiratory health of children. Int J Epidemiol 1992;21:66–73.PubMedCrossRefGoogle Scholar
  34. 34.
    Joakkola JJK, Paunio M, Virtanen M, Heinonen OP. Lowlevel air pollution and upper respiratory infections in children. Am J Pub Health 1991;81:1060–1063.CrossRefGoogle Scholar
  35. 35.
    Otten FWA, Grote JJ. Otitis media with effusion and chronic upper respiratory tract infection in children. Laryngoscope 1990; 100:627–633.PubMedCrossRefGoogle Scholar
  36. 36.
    Corren J, Rachelefsky GS. Interrelationship between sinusitis and asthma. Immunol Allergy Clin North Am 1994;14:171–184.Google Scholar
  37. 37.
    Sinreich SJ. Imaging of chronic sinusitis in adults: X-ray, computed tomography and magnetic resonance imaging. J Allergy Clin Immunol 1992;90:445–451.CrossRefGoogle Scholar
  38. 38.
    Aust R, Drettner B. Oxygen tension in the human maxillary sinus under normal and pathological conditions. Acta Otolaryngol (Stockh) 1974;78:264–269.CrossRefGoogle Scholar
  39. 39.
    Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990;103(Suppl.):880–883.PubMedGoogle Scholar
  40. 40.
    Mabry RL. Therapeutic agents in the medical management of sinusitis. Otolaryngol Clin North Am 1993; 26:561–570.PubMedGoogle Scholar
  41. 41.
    Zeiger RS. Prospects of ancillary treatment of sinusitis in the 1990s. J Allergy Clin Immunol 1992;90:478–495.PubMedCrossRefGoogle Scholar
  42. 42.
    Stapleton F, Seal DV, Dart J. Possible environmental sources of Acanthamoeba species that cause keratitis in contact lens wearers. Rev Infect Disease 1991; 13(Suppl. 5):5892.Google Scholar
  43. 43.
    Okki M, Hasigawa M, Kurita N, Watanabe I. Effects of exercise on nasal resistance and nasal blood flow. Acta Otolaryngol (Stockh) 1987; 104:328–333.CrossRefGoogle Scholar
  44. 44.
    Juto JE, Lungberg C. Nasal mucosal reactions, catecholamines and lactate during physical exercise. Acta Otolaryngol (Stockh) 1984;98:533,534.CrossRefGoogle Scholar
  45. 45.
    Melen I, Andreasson L, Ivarsson A, et al. Effects of phenylpropanolamine on ostial and nasal airway resistance in healthy individuals. Acta Otolaryngol (Stockh) 1986;102:99–105.CrossRefGoogle Scholar
  46. 46.
    Akerlund A, Bende M. Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis. Am J Rhinol 1991;5:157–160.CrossRefGoogle Scholar
  47. 47.
    Wanner A. The current status of mucolytic drugs. Contemp Int Med 1991;3:29–37.Google Scholar
  48. 48.
    Hirsch SR, Kory RC. An evaluation of the effect of nebulized N-acetylcysteine on sputum consistency. J Allergy 1978;39:265–273.CrossRefGoogle Scholar
  49. 49.
    Ziment I. Acetylcysteine: a drug with an interesting past and a fascinating future. Respiration 1986;50(Suppl. l):26–30.PubMedCrossRefGoogle Scholar
  50. 50.
    Boman G, Backer U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983;64:405–415.PubMedGoogle Scholar
  51. 51.
    Edwards GF, Steel AE, Scott JK, Jordan JW. S-carboxymethylcysteine in the fluidation of sputum and treatment of chronic airway obstruction. Chest 1976;70:506–513.PubMedCrossRefGoogle Scholar
  52. 52.
    Sakakura Y, Majima Y, Ukai SS, Miyoshi Y. Reversibility of reduced mucociliary clearance in chronic sinusitis. Clin Otolaryngol 1985; 10:79–83.PubMedCrossRefGoogle Scholar
  53. 53.
    Majima Y, Hirata K, Takeuchi K, Hattari M, et al. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am Rev Respir Dis 1990;141:79–83.PubMedGoogle Scholar
  54. 54.
    Petty TL. The National Mucolytic Study: results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990;97:75–83.PubMedCrossRefGoogle Scholar
  55. 55.
    Hirsch SR, Viernes PF, Kory RC. The expectorant effect of glycerol guaiacolate in patients with chronic bronchitis (a controlled in vitro and in vivo study). Chest 1973;63:9–14.PubMedCrossRefGoogle Scholar
  56. 56.
    Meltzer EO, Orge HA, Backhaus JW, Busse WW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92: 812–823.PubMedCrossRefGoogle Scholar
  57. 57.
    Cuenant G, Stipon JP, Plante-Longchamp G, et al. Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORI. J Otorhinolaryngol Relat Spec 1986; 48:226–232.CrossRefGoogle Scholar
  58. 58.
    Sykes DA, Chan KL, Wilson R, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: a controlled study. Lancet 1986;2:159,160.Google Scholar
  59. 59.
    Lildholdt T, Fogstrup J, Gammelgaard N, et al. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol (Stockh) 1988; 105:140–143.CrossRefGoogle Scholar
  60. 60.
    Holmberg K, Pipkorn U. Influence of topical beclomethasone dipropionate suspension on human nasal mucociliary activity. Eur J Clin Pharmacol 1986;30: 625–627.PubMedCrossRefGoogle Scholar
  61. 61.
    Dechateau GSMJE, Zuidema J, Merkus HM. The in vitro and in vivo effect of a new non-halogenated corticosteroid-budesonide aerosol on human ciliary epithelial function. Allergy 1986;41:260–265.CrossRefGoogle Scholar
  62. 62.
    Brown E, Seideman T, Siegelaub AB, Popvitz C. Depomethylprednisolone in the treatment of ragweed hay fever. Ann Allergy 1960; 18:1321–1330.Google Scholar
  63. 63.
    Sederberg-Olsen JF, Sederberg-Olsen AE. Intranasal sodium cromoglycate in post-catarrhal hyperreactive rhinosinusitis: a double-blind placebo controlled trial. Rhinol 1989;27:251–255.Google Scholar
  64. 64.
    Nelson BL, Jacob RL. Response of the nonallergic rhinitis with eosinophilia (NARES) syndrome to 4% cromolyn sodium nasal solution. J Allergy Clin Immunol 1982;70:125–128.PubMedCrossRefGoogle Scholar
  65. 65.
    Roszko R, Bornsky E, Druce H, Findlay F, et al. Ipratroprium bromide nasal spray 0.03%. Assessment of efficacy and safety in non-allergic perennial rhinitis. J Allergy Clin Immunol 1993;91:196.Google Scholar
  66. 66.
    El-Mallah ME, Abul-Khair MM, El-Hadidi SS, Fouda EE, et al. Furosemide spray in inhalation allergic rhinitis. J Allergy Clin Immunol 1993;91:260.Google Scholar
  67. 67.
    Prat J, Mullal J, Ramis I, Rosello-Catafan J, et al. Release of chemical mediators and inflammatory cell influx during early allergic reaction in the nose: effect of furosemide. J Allergy Clin Immunol 1993;92:248–254.PubMedCrossRefGoogle Scholar
  68. 68.
    Druce HM. Medical management of sinusitis in the adult. In: Druce HM, ed. Sinusitis. New York: Marcel Dekker 1994; pp. 73–85.Google Scholar
  69. 69.
    Cole P, Haight JS. Posture and nasal patency. Am Rev Respir Dis 1984; 129:351–354.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Christopher Chang
  • Stanley Naguwa

There are no affiliations available

Personalised recommendations